Skip to content
Gadodiamide
Omniscan (gadodiamide) is a small molecule pharmaceutical. Gadodiamide was first approved as Omniscan on 1993-01-08.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Omniscan
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Gadodiamide
Tradename
Company
Number
Date
Products
OMNISCANGE HealthcareN-020123 RX1993-01-08
1 products, RLD, RS
OMNISCANGE HealthcareN-022066 RX2007-09-05
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
omniscanNew Drug Application2022-12-30
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V08: Contrast media
— V08C: Magnetic resonance imaging contrast media
— V08CA: Paramagnetic contrast media
— V08CA03: Gadodiamide
HCPCS
No data
Clinical
Clinical Trials
6 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CognitionD003071EFO_0003925———1—1
Nephrogenic fibrosing dermopathyD054989EFO_1001814———1—1
Chronic renal insufficiencyD051436N18———1—1
Renal insufficiencyD051437HP_0000083N19———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Arterial occlusive diseasesD001157EFO_0009085——1——1
Renal artery obstructionD012078EFO_1001150N28.0——1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C61————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameGADODIAMIDE
INNgadodiamide
Description
Gadodiamide, sold under the brand name Omniscan, is a gadolinium-based MRI contrast agent (GBCA), used in magnetic resonance imaging (MRI) procedures to assist in the visualization of blood vessels.
Classification
Small molecule
Drug classgadolinium derivatives (principally for diagnostic use)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CNC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)NC)CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
Identifiers
PDB—
CAS-ID122795-43-1
RxCUI41144
ChEMBL IDCHEMBL1200346
ChEBI ID37333
PubChem CID60754
DrugBankDB00225
UNII ID84F6U3J2R6 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 3,084 documents
View more details
Safety
Black-box Warning
Black-box warning for: Omniscan
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
5,850 adverse events reported
View more details